NCT06505551 2024-07-17Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive CarcinomaSCG Cell Therapy Pte. Ltd.Phase 1/2 Not yet recruiting66 enrolled